Lappe Mark 的 Form 4 申報
Inhibrx Biosciences, Inc.（INBX），2026/9/8 申報
- 申報編號
- 0001366074-26-000002
- 申報時間
- 2026/9/8 16:04 ET
- 交易日
- 2026/9/8
- 申報延遲
- 當天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 6 筆非衍生性交易。公開市場買進合計 $264.5 萬。交易當天就申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lappe MarkCIK 0001366074 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/9/8 | Common Stock | P買進取得 | +5,895 | $99.29F1 | +$585,342.85 | 711,443 | 間接 | |
| 2026/9/8 | Common Stock | P買進取得 | +6,605 | $100.64F3 | +$664,719.27 | 718,048 | 間接 | |
| 2026/9/8 | Common Stock | P買進取得 | +1,100 | $107.12F4 | +$117,836.29 | 719,148 | 間接 | |
| 2026/9/8 | Common Stock | P買進取得 | +500 | $108.24F5 | +$54,117.5 | 719,648 | 間接 | |
| 2026/9/8 | Common Stock | P買進取得 | +1,219 | $111.88F6 | +$136,382.33 | 720,867 | 間接 | |
| 2026/9/8 | Common Stock | P買進取得 | +9,681 | $112.28F7 | +$1,087,001.07 | 730,548 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The shares were purchased in multiple transactions at prices ranging from $98.88 to $99.8316 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The shares were purchased in multiple transactions at prices ranging from $100.095 to $100.99 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The shares were purchased in multiple transactions at prices ranging from $106.6225 to $107.57 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The shares were purchased in multiple transactions at prices ranging from $108.05 to $108.66 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The shares were purchased in multiple transactions at prices ranging from $111.15 to $112.07 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The shares were purchased in multiple transactions at prices ranging from $112.15 to $112.44 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。